Annual report
6960.TEDINET S100TU7S
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥140.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥134.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥146.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥133.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥26.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥24.1bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥27.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥25.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥27.0bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥25.2bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥18.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥14.7bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.6bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥18.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥209.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥206.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥195.5bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥191.8bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥168.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥40.1bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥43.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥169.0bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥163.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥149.9bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥138.0bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥124.4bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥60.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥68.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥57.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥61.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥46.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥23.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥21.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥20.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥14.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥17.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥622.44 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥571.25 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥536.19 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥486.67 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥316.52 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥5,863.22 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,390.09 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,954.7 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,562.94 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,114.98 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 80.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.3% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,443 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 3,382 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 3,348 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 3,291 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 3,208 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥87.0bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥82.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥82.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥81.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥71.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥14.5bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥12.4bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥21.2bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥18.5bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥18.0bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.9bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥21.4bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥18.7bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥17.1bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥14.8bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥14.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥177.6bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥176.0bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥163.5bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥158.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥137.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥46.9bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥48.8bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥130.7bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥127.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥117.1bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥107.2bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥96.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥37.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥46.1bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥567.96 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥489.27 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥477.6 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥397.01 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥264.8 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥185 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥240 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥305 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥275 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥4,534.7 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,204.87 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,871.21 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,543.95 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,199.28 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 73.6% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.6% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.9% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 37,747,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,176,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 699 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 690 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 669 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 659 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 651 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥97.2bn |
| Consumables And Other Productsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| Consumables And Other Productsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥757m |
| Consumables And Other Productsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥40.2bn |
| Consumables And Other Productsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥40.2bn |
| Consumables And Other Productsreportable segment | segment assets | at 2024-03-31 | ¥27.3bn |
| Consumables And Other Productsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥6.9bn |
| Medical Treatment Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥11.7bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥8.2bn |
| Medical Treatment Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥59.7bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥59.7bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2024-03-31 | ¥56.0bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥12.8bn |
| Patient Monitoring Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥384m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥182m |
| Patient Monitoring Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2024-03-31 | ¥7.6bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥577m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥30.7bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥30.7bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2024-03-31 | ¥21.1bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥5.1bn |
| —segment total | employees | at 2024-03-31 | 2740 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥14.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥140.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥140.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥111.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥26.5bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥100.1bn |
| Consumables And Other Productsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Consumables And Other Productsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥699m |
| Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥36.5bn |
| Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥36.5bn |
| Consumables And Other Productsreportable segment | segment assets | at 2023-03-31 | ¥25.7bn |
| Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥4.7bn |
| Medical Treatment Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8.3bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥7.9bn |
| Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥55.4bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥55.4bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2023-03-31 | ¥50.7bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥12.4bn |
| Patient Monitoring Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥417m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥222m |
| Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥11.6bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥11.6bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2023-03-31 | ¥8.7bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥594m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥31.1bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥31.1bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2023-03-31 | ¥21.7bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥11.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥134.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥134.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥106.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥24.1bn |
| —segment total | employees | at 2024-03-31 | 591 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,684
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision of allowance for doubtful accounts sga | Prior1YearDuration_NonConsolidatedMember | -158000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration_NonConsolidatedMember | -115000000 | JPY |
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 3773000000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 4728000000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 1146000000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 994000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-06-27 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第77期（自 2023年４月１日 至 2024年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)フクダ電子株式会社 | |
| Company name in english cover page | FilingDateInstant | FUKUDA DENSHI CO., LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 白井 大治郎 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都文京区本郷三丁目39番４号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)(03)3815-2121（大代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)社長室経理部長 本部 晴彦 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都文京区本郷三丁目39番４号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)(03)3815-2121（大代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)社長室経理部長 本部 晴彦 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02304 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 69600 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)フクダ電子株式会社 | |
| Filer name in english | FilingDateInstant | FUKUDA DENSHI CO., LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Current period end date | FilingDateInstant | 2024-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Comparative period end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |